Singapore - Engels - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - radium-223 chloride - injection, solution (radiopharmaceutical) - 1000 kbq/ml - radium-223 chloride 1100 kbq/ml

Singapore - Engels - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - eptifibatide - injection - 2 mg/ml - eptifibatide 2 mg/ml

Singapore - Engels - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - eptifibatide - injection - 0.75 mg/ml - eptifibatide 0.75 mg/ml

Singapore - Engels - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - regorafenib monohydrate 41.49mg eqv regorafenib - tablet, film coated - 40.00mg - regorafenib monohydrate 41.49mg eqv regorafenib 40.00mg

Singapore - Engels - HSA (Health Sciences Authority)

roche singapore pte. ltd. - vemurafenib in hypromellose acetate succinate 800mg eqv to vemurafenib - tablet, film coated - 240mg - vemurafenib in hypromellose acetate succinate 800mg eqv to vemurafenib 240mg

Singapore - Engels - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - sugammadex sodium 108.8mg eqv sugammadex - injection, solution - 100mg - sugammadex sodium 108.8mg eqv sugammadex 100mg

Singapore - Engels - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - canakinumab - powder, for solution - 150mg - canakinumab 150mg

Singapore - Engels - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - rivastigmine (as base) - patch, extended release - 27.000 mg - rivastigmine (as base) 27.000 mg

Europese Unie - Engels - EMA (European Medicines Agency)

zoetis belgium sa - dibotermin alfa - bone morphogenetic proteins - dogs - osteoinductive agent for use in the treatment of long-bone fractures as an adjunct to standard surgical care using open fracture reduction in dogs.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

corcym pty ltd - 45578 - mitral/tricuspid annuloplasty ring - the memo 3d rechord device is an annuloplasty ring consisting of an inner core metal alloy enclosed in a sewing ring of silicone and knitted polyester fabric. the fabric is coated with carbofilm, a thin layer of turbostratic carbon. the ring exhibits flexibility to accomodate the three-dimensional annulus motion. to support the remodeling, the flexibility is maximal in the posterior curved portion and gradually decreases towards the anterior linear segment. the use of the memo 3d rechord device is indicated for correction of congenital or acquired mitral insuffi ciencies with dilatation and deformation of the mitral annulus. type i insufficiencies, with no manifest lesions in the subvalvular apparatus, can be treated with the implant of the annuloplasty ring on its own. for type ii insufficiencies,characterised by valve prolapse sustained by elongation/ breakage of the chordae tendineae and papillary muscles, and type iii insufficiencies, characterised by partially immobilised leaflets due to the fusion/hypertrophy of the chordae tendineae, the device implantation must be accompanied by corrective valvuloplasty.